Loading...

Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study

INTRODUCTION: The aim of the study was to assess the safety and efficacy of darunavir (Prezista(®)) used in subtype F human immunodeficiency virus – type 1 (HIV-1) infected, antiretroviral therapy (ART)-experienced patients in Romania in routine clinical practice. METHODS: This was a post-authorizat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Benea, Otilia Elisabeta, Streinu-Cercel, Adrian, Dorobăţ, Carmen, Rugină, Sorin, Negruţiu, Lucian, Cupşa, Augustin, Duiculescu, Dan, Chiriac, Carmen, Itu, Corina, Prisăcariu, Liviu Jany, Iosif, Ionel
Format: Artigo
Sprog:Inglês
Udgivet: National Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Romania, and the European Academy of HIV/AIDS and Infectious Diseases 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176257/
https://ncbi.nlm.nih.gov/pubmed/25276665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11599/germs.2014.1057
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!